Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Creative Medical Technology Holdings (CELZ) Gross Profit (2017 - 2025)

Creative Medical Technology Holdings (CELZ) has disclosed Gross Profit for 9 consecutive years, with $1800.0 as the latest value for Q1 2025.

  • On a quarterly basis, Gross Profit changed N/A to $1800.0 in Q1 2025 year-over-year; TTM through Sep 2025 was $3600.0, a 45.45% decrease, with the full-year FY2024 number at $6600.0, up 22.22% from a year prior.
  • Gross Profit was $1800.0 for Q1 2025 at Creative Medical Technology Holdings, roughly flat from $1800.0 in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $39000.0 in Q3 2022 to a low of $1800.0 in Q4 2023.
  • A 5-year average of $10337.6 and a median of $5500.0 in 2021 define the central range for Gross Profit.
  • Peak YoY movement for Gross Profit: skyrocketed 550.0% in 2022, then tumbled 90.77% in 2023.
  • Creative Medical Technology Holdings' Gross Profit stood at $28305.0 in 2021, then crashed by 54.43% to $12900.0 in 2022, then tumbled by 86.05% to $1800.0 in 2023, then changed by 0.0% to $1800.0 in 2024, then changed by 0.0% to $1800.0 in 2025.
  • Per Business Quant, the three most recent readings for CELZ's Gross Profit are $1800.0 (Q1 2025), $1800.0 (Q4 2024), and $4800.0 (Q2 2024).